Technische Universität München
Stories about Pediatrics
- more
Norgine B.V. Announces New European Healthcare Subsidiary To Strengthen Its Consumer Healthcare Portfolio
moreVolvo's Backwards Thinking: why facing rearwards is the safest way of travel for your child
moreRegulatory breakthrough for BrainRepair UG start-up - Stem cell treatment for newborns /EMA Orphan Drug Designation is followed by agreement on Paediatric Investigation Plan
moreMerck Advances Oncology Portfolio and Pipeline with New and Long-term Data in Multiple Cancers at ESMO 2020
moreFinal Phase II Results for UCB's Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) Published in Blood Advances
moreCarag Receives U.S. FDA IDE Approval to Conduct Clinical Study of First Transcatheter Septal Occluder With Bioresorbable, Metal-free Framework
moreElse Kröner-Fresenius-Stiftung
Groundbreaking Gene Therapies for Hereditary Diseases / Alessandro Aiuti, a physician and research scientist from Milan, receives the Else Kröner Fresenius Prize for Medical Research 2020 endowed with 2.5 million euros
moreTechnische Universität München
A disease trigger for pancreatitis has been identified
moreSaxenda® Demonstrated Improvements in BMI and Body Weight in Adolescents With Obesity
moreCarag First-ever Septal Occluder With Bioresorbable, Metal-free Framework Available to Patients Through New European Registry
morePositive signs for further growth in Asia: Syntellix receives product approvals in Malaysia and Myanmar earlier than planned
moreFresenius Kabi Deutschland GmbH
A new expert consensus publication provides practical guidance on the use of omega-3 fatty acids in parenteral nutrition
moreSTADA to acquire established OTC and food supplement portfolio in the Philippines
One documentmoreEuropean Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma
moreUEG Week Exhibition Celebrates 50 Years of Colonoscopy in Preventing and Diagnosing Gastrointestinal Diseases, Including Colorectal Cancer
moreCampus Klinik an der Ruhr-Universität Bochum
Unique index at birth predicts disability at 4 years of age / Fetal Growth determines preschool performance
moreMallinckrodt Announces 2019 Investigator Award for Pioneering Efforts in ECP Immunomodulation
morePrimex Pharmaceuticals and Nordic Group Sign a Strategic Partnership to Commercialise OZALIN® in France
morePrimex Pharmaceuticals and POA Pharma Sign a Strategic Partnership to Commercialise OZALIN in the Nordic Region
morePivotal Phase III Data for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine
moreFDA Accepts sBLA and Grants Priority Review for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) for the Treatment of Advanced Renal Cell Carcinoma
moreCartiHeal Performs First Agili-C(TM) Cartilage Repair Implantation Procedures at Missouri Orthopaedic Institute
moreNew Phase 2 Data for Somapacitan Demonstrate Its Potential as an Efficacious Once-weekly Treatment for Childhood Growth Hormone Deficiency
moreBAVENCIO® (avelumab) Plus INLYTA® (axitinib) Significantly Improved Progression-Free Survival in Previously Untreated Patients With Advanced Renal Cell Carcinoma in Phase III Study
more
1